UPDATE : Monday, September 7, 2020
상단여백
HOME Pharma
SK Chemicals aims to dominate shingles vaccine market with Skyzoster
  • By Marian Chu
  • Published 2018.02.20 14:30
  • Updated 2018.02.20 14:30
  • comments 0

SK Chemicals is aiming to become a leading shingles vaccines developer by grabbing half of the domestic market share this year, the company said Tuesday.

“SK Chemicals plans to increase Skyzoster’s market share to 50 percent by the end of this year, keeping the initial momentum,” the company said. Skyzoster is the first domestically developed shingles vaccine and the world’s second such vaccine.

Professor Cheong Hee-jin from Korea University Guro Hospital presents clinical data at the Skyzoster launching symposium held at the InterContinental Seoul Coex on Feb. 8.

The pharmaceutical division of Korean conglomerate SK Group began supplying the vaccine to local hospitals and clinics in December. Sales of Skyzoster reached 5 billion won ($4.67 million) by the second week of February. SK Chemicals expects to record more than 8 billion won by the end of this month, it said.

“More than 1,100 people in Korea alone are potential target groups of the shingles vaccine,” said Ahn Jae-yong, head of the SK Chemicals vaccine division. “We will contribute to protecting the national health by providing a stable supply of the Skyzoster produced by the L House, a state-of-the-art production facility, to the shingles vaccine market.”

The domestic shingles vaccine market is expected to exceed 100 billion won by the end of this year, according to the company.

SK Chemicals said it has ramped up production at its factory due to increased supply of Skyzoster to general hospitals as well as more requests for the shingles vaccine from community clinics. The company also said it ran symposiums in seven cities over the past month to introduce the vaccine to local physicians.

yjc@docdocdoc.co.kr

<© Korea Biomedical Review, All rights reserved.>

Other articles by Marian Chu
iconMost viewed
Comments 0
More
Please leave the first comment.
여백
여백
여백
Back to Top